Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study. [electronic resource]
Producer: 20100525Description: 2418-20 p. digitalISSN:- 1556-5653
- Adolescent
- Adult
- Female
- Follicle Stimulating Hormone -- administration & dosage
- Follow-Up Studies
- Gonadotropin-Releasing Hormone -- administration & dosage
- Humans
- Luteal Phase -- drug effects
- Menotropins -- administration & dosage
- Oocyte Donation -- methods
- Ovarian Hyperstimulation Syndrome -- etiology
- Ovulation Induction -- methods
- Recombinant Proteins -- administration & dosage
- Risk Factors
- Time Factors
- Tissue Donors
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.